Researchers Take a Step Forward in Developing Bioengineered Protein Against COVID-19
March 21, 2024| |
Using a combination of protein engineering and computational design, researchers from NYU Tandon School of Engineering present a new method in addition to an array of treatment modalities against COVID-19. Their research is published in the Biochemical Engineering Journal.
The study, led by Dr. Jin Kim Montclare, aimed to develop an engineered protein that can attach to the spike proteins on the surface of the coronavirus and small molecules, such as the antiviral drug Ritonavir. Integrating Ritonavir into the protein could enhance the efficiency of the treatment by simultaneously targeting the virus directly.
While the study is still in its early stages with no human or animal trials yet, the findings show great promise in combatting different variants of SARS-CoV-2. This research opens new opportunities for developing a unique approach to targeting and treating viral threats and infections.
For more information, read the article from NYU Tandon School of Engineering.
| |
You might also like:
- Pocket K No. 58: COVID-19 Treatment Efforts Using Plant Technologies
- Scientists Say COVID-19 Coronavirus Has Natural Origins
- New COVID-19 Therapy Uses Plants
Biotech Updates is a weekly newsletter of ISAAA, a not-for-profit organization. It is distributed for free to over 22,000 subscribers worldwide to inform them about the key developments in biosciences, especially in biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
-
See more articles:
-
Plant
- Experts in Australia Find Ways to Improve Disease Resistance of Narrow-leafed Lupins
- Gene Knockout Provides Insights to Reducing Cadmium in Rice Grains
- Study Unveils the Role of CAX1 Gene in Improving Plant Tolerance to Flooding
-
Food
- FSANZ Calls for Comments on Food Derived from GM Corn MON94804
- Study Shows Growing Plants in Space without Human Intervention Possible
- Transgenic Cow Generates Milk With Human Insulin
-
Health
- GM Bacterium Produces Precursor of an Alzheimer's Drug
- Researchers Take a Step Forward in Developing Bioengineered Protein Against COVID-19
-
Read the latest: - Biotech Updates (May 8, 2024)
- Gene Editing Supplement (April 24, 2024)
- Gene Drive Supplement (February 22, 2023)
-
Subscribe to BU: - Share
- Tweet